Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype ; volume:5 ; number:1 ; day:24 ; month:2 ; year:2016 ; pages:1-9 ; date:12.2016
SpringerPlus ; 5, Heft 1 (24.2.2016), 1-9, 12.2016
- Creator
-
Fukuda, Takayo
- Contributor
-
Horii, Rie
Gomi, Naoya
Miyagi, Yumi
Takahashi, Shunji
Itō, Yoshinori
Akiyama, Futoshi
Ohno, Shinji
Iwase, Takuji
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-1800-x
- URN
-
urn:nbn:de:1111-201602255582
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fukuda, Takayo
- Horii, Rie
- Gomi, Naoya
- Miyagi, Yumi
- Takahashi, Shunji
- Itō, Yoshinori
- Akiyama, Futoshi
- Ohno, Shinji
- Iwase, Takuji
- SpringerLink (Online service)
Other Objects (12)
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Radiation Management for Breast Cancer After Neoadjuvant Therapy
Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Radiation Management for Breast Cancer After Neoadjuvant Therapy
Shrink pattern of breast cancer after neoadjuvant chemotherapy and its correlation with clinical pathological factors
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study
Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
Prediction of neoadjuvant chemotherapy response in breast cancer
Neoadjuvant Treatment of Breast Cancer - Advances and Limitations
Radiation Management for Breast Cancer After Neoadjuvant Therapy